Cancer is today's deadliest disease, but by 2050 drug-resistant bacterial infections are projected to become the leading cause of death.
Antibiotics are steadily losing effectiveness against resistant bacteria, opening a critical gap in treatment.
The 'Risks' chart contrasts projected antimicrobial resistance (AMR) mortality (10M by 2050) with today's causes of death like cancer, diarrhoeal disease, and road accidents.
More detail
Source cited on slide: aiehta.com AMR mortality projections.
02 / The biology
frame_01m00s.png
Bacteriophages ('phages') are viruses that infect bacteria: the most abundant organisms on Earth and the natural predators of bacteria.
A phage binds to a bacterium, injects its genomic code, hijacks the host, replicates, and kills the bacterium in the process.
Phage therapy offers a complement or alternative to conventional antibiotic treatment.
Before clinical use, phage genomes must be studied carefully to avoid accidentally introducing genes harmful to patients.
More detail
Eugenie Grosboillot works on the isolation, characterization, and propagation of phages.
03 / The problem
frame_01m51s.png
Phage sequences live in messy, semi-structured text files with hand-made annotations that are inconsistent, sometimes incomplete, and vary by pipeline.
Bioinformatics pipelines are lengthy: a run can fail an hour in because of one mislocalized or malformed file, which is deeply frustrating.
Portability matters: the same pipeline must run locally on a laptop and on high-performance computing (HPC) environments.
The slide maps the full landscape of lab, experiment, and data challenges, from reproducibility to file formats to analysis at scale.
04 / The solution
frame_04m21s.png
Synphage analyzes large collections of phage genomic sequences in a single blow.